Santa Barbara County ‘Close’ to Reaching Testing Agreement with Unvaccinated Deputies

Santa Barbara County ‘Close’ to Reaching Testing Agreement with Unvaccinated Deputies title=
Sheriff Bill Brown promotes nine deputies in 2017, including Neil Gowing (far left), current president of the Deputy Sheriff's Association. | Credit: Courtesy
16 Comments
Reads 2937

This story was originally published by the Santa Barbara Independent and is reproduced here in partnership with Edhat.


By Tyler Hayden of The Independent

Three months after Santa Barbara County’s vaccine-or-test mandate for its workforce went into effect, officials say they are close to reaching an agreement with approximately 100 Sheriff’s deputies who remain both unvaccinated and untested

“The good news is, we’re close to a resolution,” said Joe Pisano with the county’s Human Resources Department, explaining that tentatively switching from a national testing provider to a local one seems to have mollified the patrol deputies’ concerns over their medical privacy. But when the process can actually begin remains to be seen. “Unfortunately, the Omicron surge has narrowed the bandwidth of all the parties,” Pisano said, “so I cannot say for sure when a potential contract might be in place.”

The holdup, Pisano said, has hinged on an agreement clause within registration materials used by the county’s original provider, Color, a Bay Area–based health technology firm that conducts large-scale COVID-19 testing for private companies and public agencies across the country. It reads: “I understand that my personal and health-related information (including my results) will be shared with clinical and other staff at the testing site, as well as the California Department of Public Health, for treatment and follow-up care purposes.”

The deputies took that language to mean any and all of their medical information, including information unrelated to their COVID tests, could be disseminated, despite assurances from county officials. “I do not believe Color would have access to any medical information aside from the test results,” Pisano said. 

But to assuage any lingering worries, the county is now in talks with Aptitude, a Goleta biotech company that, unlike Color, does all its sample collecting and processing in-house. “The deputies like that it’s local,” Pisano said, “and they like that it’s one-stop shopping.” Aptitude is currently providing its services to Santa Barbara schools. A representative said because a contract was not yet in place, he could not provide even a rough timeline of when their work with the deputies might begin.

The Deputy Sheriff’s Association has led the negotiations with the county. The union’s president, Sgt. Neil Gowing, said of the pending compromise, “We are happy that we were able to find a solution that was acceptable to both parties and also to keep our business local.

Login to add Comments

16 Comments

Show Comments
Sun Jan 13, 2022 01:07 PM
Santa Barbara County ‘Close’ to Reaching Testing Agreement with Unvaccinated Deputies

This is interesting....
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
https://pubmed.ncbi.nlm.nih.gov/35007072/

As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection-mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid acids from hemp (Cannabis sativa) were found to be allosteric as well as orthosteric ligands with micromolar affinity for the spike protein. In follow-up virus neutralization assays, cannabigerolic acid and cannabidiolic acid prevented infection of human epithelial cells by a pseudovirus expressing the SARS-CoV-2 spike protein and prevented entry of live SARS-CoV-2 into cells. Importantly, cannabigerolic acid and cannabidiolic acid were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2.

Could cannabis help fight Covid? New study reveals two chemicals that may block infection

https://www.yahoo.com/news/cannabis-plants-prevent-covid-infection-010111572.html
The two compounds that worked best were cannabigerolic acid, known as CBG-A, and cannabidiolic acid, known as CBD-A, both precursors to the better-known chemicals in cannabis drugs.

The former exists only while the cannabis plant is growing, while the latter is converted into CBD, one of the key ingredients in recreational and medicinal cannabis, through burning, vaping or baking.

The chemicals worked well against both the alpha and beta variants of coronavirus, raising the prospect that they might also function against Omicron and other mutations.

"Our data show CBDA and CBGA are effective against the two variants we looked at, and we hope that trend will extend to other existing and future variants," said Mr van Breemen.

Sun Jan 14, 2022 08:34 AM
Santa Barbara County ‘Close’ to Reaching Testing Agreement with Unvaccinated Deputies

@...686 It is insulting to the scientist who are trying to make a difference, for You to compare their work to bleach....I never said don't get vaccinated I stated that this is interesting... imply that new research can help in the fight for covid-19. It would appear
you have no understanding of the long history of cannabis use for many diseases. Because it is not a synthetic drug, one which the brain recognizes and responds to, it has been used to help reduce negative symptoms of many diseases....

Sun Jan 13, 2022 03:39 PM
Santa Barbara County ‘Close’ to Reaching Testing Agreement with Unvaccinated Deputies

Using all the tools we have to fight covid-19 helps....

Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

https://pubmed.ncbi.nlm.nih.gov/33758843/

The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection, inhibiting viral gene expression and reversing many effects of SARS-CoV-2 on host gene transcription. CBD induces interferon expression and up-regulates its antiviral signaling pathway. A cohort of human patients previously taking CBD had significantly lower SARSCoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population. This study highlights CBD, and its active metabolite, 7-OH-CBD, as potential preventative agents and therapeutic treatments for SARS-CoV-2 at early stages of infection.

Please Login or Register to comment on this.